Impact of Long-Acting Somatostatin Analogues on Glucose Metabolism in Acromegaly: A Hospital-Based Study

<div>Flowchart of prevalence of NGT, IGT, and DM at pretreatment and after SSA treatment, and the change of glucose metabolism status after SSA therapy. NGT: normal glucose tolerance; IGT: impaired glucose tolerance; DM: diabetes mellitus.</div>

International Journal of Endocrinology

fig1

Figure 1

Figure 1: Impact of Long-Acting Somatostatin Analogues on Glucose Metabolism in Acromegaly: A Hospital-Based Study 